Asthma and COPD added to CAI's Cellular Disease Models
SAN DIEGO, Aug 29, 2016 -- To facilitate basic research and development of airway drugs, Cell Applications now offers a panel of primary cells for use in Asthma and COPD studies. The cells, isolated from donors afflicted by the diseases, include Bronchial & Tracheal Epithelial Cells, Pulmonary & Lung Microvascular Endothelial cells and others. Multiple donor profiles and lots are available.Asthma and Chronic Obstructive Pulmonary Disease are both long-term diseases, where genetic, environmental and lifestyle factors cause the lungs and airways to deliver poor air flow. “The resulting shortness of breath can be life-threatening in severe or end-stage cases,” says Dr. Daniel Schroen, Vice President of Sales and Marketing at Cell Application. “There’s no cure for either, and asthma often begins in early childhood. We want to help life science researchers and pharmaceutical companies make strides in understanding, treating and managing the diseases.”
Press & Media Relations
Daniel Schroen, PhD
VP, Sales & Marketing
(858) 453-0848